Devenir des stents en nitinol sur les artères fémorales superficielles et poplitées dans une population âgée

DeRubertis, 2007, Shifting paradigms in the treatment of lower extremity vascular disease: a report of 1,000 percutaneous interventions, Ann Surg, 246, 415, 10.1097/SLA.0b013e31814699a2 Surowiec, 2005, Percutaneous angioplasty and stenting of the superficial femoral artery, J Vasc Surg, 41, 269, 10.1016/j.jvs.2004.11.031 Ferreira, 2007, Superficial femoral artery recanalization with self-expanding nitinol stents: long-term follow-up results, Eur J Vasc Endovasc Surg, 34, 702, 10.1016/j.ejvs.2007.07.025 Schillinger, 2006, Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery, N Engl J Med, 354, 1879, 10.1056/NEJMoa051303 Dick, 2009, Balloon angioplasty versus stenting with nitinol stents in intermediate length superficial femoral artery lesions, Catheter Cardiovasc Interv, 74, 1090, 10.1002/ccd.22128 Mwipatayi, 2008, Balloon angioplasty compared with stenting for treatment of femoropopliteal occlusive disease: a meta-analysis, J Vasc Surg, 47, 461, 10.1016/j.jvs.2007.07.059 Twine, 2009, Angioplasty versus stenting for superficial femoral artery lesions, Cochrane Database Syst Rev (Online), CD006767 Minar, 2009, New stents for SFA, J Cardiovas Surg, 50, 635 Bosiers, 2009, Nitinol stent implantation in long superficial femoral artery lesions: 12-month results of the DURABILITY I study, J Endovasc Ther, 16, 261, 10.1583/08-2676.1 Schmieder, 2008, Selective stenting in subintimal angioplasty: analysis of primary stent outcomes, J Vasc Surg, 48, 1175, 10.1016/j.jvs.2008.05.080 Davies, 2008, Impact of runoff on superficial femoral artery endoluminal interventions for rest pain and tissue loss, J Vasc Surg, 48, 619, 10.1016/j.jvs.2008.04.013 DeRubertis, 2008, Percutaneous intervention for infrainguinal occlusive disease in women: equivalent outcomes despite increased severity of disease compared with men, J Vasc Surg, 48, 150, 10.1016/j.jvs.2008.03.007 Davies, 2008, Percutaneous superficial femoral artery interventions for claudication–does runoff matter?, Ann Vasc Surg, 22, 790, 10.1016/j.avsg.2008.04.007 Ihnat, 2008, Contemporary outcomes after superficial femoral artery angioplasty and stenting: the influence of TASC classification and runoff score, J Vasc Surg, 47, 967, 10.1016/j.jvs.2007.12.050 Dearing, 2009, Primary stenting of the superficial femoral and popliteal artery, J Vasc Surg, 50, 542, 10.1016/j.jvs.2009.04.019 Zeller, 2008, Nitinol stent implantation in TASC A and B superficial femoral artery lesions: the Femoral Artery Conformexx Trial (FACT), J Endovasc Ther, 15, 390, 10.1583/08-2461.1 Diehm, 2008, Clinical endpoints in peripheral endovascular revascularization trials: a case for standardized definitions, Eur J Vasc Endovasc Surg, 36, 409, 10.1016/j.ejvs.2008.06.020 Rutherford, 1997, Recommended standards for reports dealing with lower extremity ischemia: revised version, J Vasc Surg, 26, 517, 10.1016/S0741-5214(97)70045-4 Dormandy, 2000, TransAtlantic Inter-Society Consensus (TASC). Management of peripheral arterial disease (PAD), J Vasc Surg, 31, S1 Wilson, 2010, Trials of endovascular treatment for superficial femoral artery occlusive lesions: a call for medically managed control patients, Ann Vasc Surg, 24, 498, 10.1016/j.avsg.2009.08.013 Baril, 2009, Duplex criteria for determination of in-stent stenosis after angioplasty and stenting of the superficial femoral artery, J Vasc Surg, 49, 133, 10.1016/j.jvs.2008.09.046 Norgren, 2007, Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II), Eur J Vasc Endovasc Surg, 33, S1, 10.1016/j.ejvs.2006.09.024